
CN Bio, an organ-on-a-chip company that designs and manufactures single and multi-organ microphysiological systems (MPS), has announced that their novel …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

